A verification study of the suppressive effect of the test food consumption on the elevation of postprandial blood glucose: a randomized, placebo-controlled, double-blind, crossover comparison trial - A verification study of the suppressive effect of the test food consumption on the elevation of postprandial blood glucose

ORTHOMEDICO Inc.0 sites36 target enrollmentJune 9, 2022

Overview

No summary available.

Registry

who.int

Start Date

June 9, 2022

End Date

December 3, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects who currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily use 5\. Subjects who currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test food related products 7\. Subjects who are pregnant, lactation, or planning to become pregnant 8\. Subjects who suffer from COVID\-19 9\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10\. Subjects who are judged as ineligible to participate in the study by the physician